RE:RE:A Press Release obviously directed to the common shareholderAgree......but the tenor of this one was a little bit different I thought. Less tech related and more thrust in wherein the share appreciation will come from. Phrases such as "full utilization of the six bioreactors" and "it can now reliably produce enough rubella antigen to supply all demand from its international customer base" and "The company has recently ordered a seventh unit". They seldom reference internal details (although still vague but enough to give us some colour). Just a different slant I thought.